7-135135199-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_178563.4(AGBL3):c.2701G>A(p.Glu901Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000511 in 1,547,240 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_178563.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AGBL3 | NM_178563.4 | c.2701G>A | p.Glu901Lys | missense_variant | 17/17 | ENST00000436302.6 | NP_848658.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AGBL3 | ENST00000436302.6 | c.2701G>A | p.Glu901Lys | missense_variant | 17/17 | 2 | NM_178563.4 | ENSP00000388275 | P2 | |
CYREN | ENST00000459937.5 | n.356+33550C>T | intron_variant, non_coding_transcript_variant | 1 | ||||||
AGBL3 | ENST00000435976.6 | c.2111-12614G>A | intron_variant | 5 | ENSP00000401220 | A2 | ||||
CYREN | ENST00000464070.1 | n.187+12778C>T | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000493 AC: 75AN: 152066Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000455 AC: 68AN: 149548Hom.: 0 AF XY: 0.000478 AC XY: 38AN XY: 79520
GnomAD4 exome AF: 0.000513 AC: 716AN: 1395056Hom.: 0 Cov.: 31 AF XY: 0.000503 AC XY: 346AN XY: 688148
GnomAD4 genome AF: 0.000493 AC: 75AN: 152184Hom.: 1 Cov.: 32 AF XY: 0.000632 AC XY: 47AN XY: 74402
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2021 | The c.2701G>A (p.E901K) alteration is located in exon 17 (coding exon 16) of the AGBL3 gene. This alteration results from a G to A substitution at nucleotide position 2701, causing the glutamic acid (E) at amino acid position 901 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at